On the latest episode of The Beagle, our President/CEO, Ellen Matloff, explains what we offer at My Gene Counsel to a typical customer who has done direct-to-consumer or clinical genetic testing for cancer susceptibility.
Today, June 13th, 2018, marks the 5-year anniversary of the Supreme Court of the United States’ Association for Molecular Pathology v. Myriad Genetics case regarding the BRCA gene patent. The result was a unanimous decision: genes could not be patented as they...
On June 13, 2013, in the case of the Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court of the United States ruled that human genes cannot be patented in the U.S. because DNA is a “product of nature.” The Court decided that...